Accurate digital quantification of tau pathology in progressive supranuclear palsy.
Digital pathology
Machine learning
Neurodegenerative diseases
PSP
Random forest
Journal
Acta neuropathologica communications
ISSN: 2051-5960
Titre abrégé: Acta Neuropathol Commun
Pays: England
ID NLM: 101610673
Informations de publication
Date de publication:
09 11 2023
09 11 2023
Historique:
received:
16
08
2023
accepted:
20
10
2023
medline:
13
11
2023
pubmed:
10
11
2023
entrez:
10
11
2023
Statut:
epublish
Résumé
The development of novel treatments for Progressive Supranuclear Palsy (PSP) is hindered by a knowledge gap of the impact of neurodegenerative neuropathology on brain structure and function. The current standard practice for measuring postmortem tau histology is semi-quantitative assessment, which is prone to inter-rater variability, time-consuming and difficult to scale. We developed and optimized a tau aggregate type-specific quantification pipeline for cortical and subcortical regions, in human brain donors with PSP. We quantified 4 tau objects ('neurofibrillary tangles', 'coiled bodies', 'tufted astrocytes', and 'tau fragments') using a probabilistic random forest machine learning classifier. The tau pipeline achieved high classification performance (F1-score > 0.90), comparable to neuropathologist inter-rater reliability in the held-out test set. Using 240 AT8 slides from 32 postmortem brains, the tau burden was correlated against the PSP pathology staging scheme using Spearman's rank correlation. We assessed whether clinical severity (PSP rating scale, PSPRS) score reflects neuropathological severity inferred from PSP stage and tau burden using Bayesian linear mixed regression. Tufted astrocyte density in cortical regions and coiled body density in subcortical regions showed the highest correlation to PSP stage (r = 0.62 and r = 0.38, respectively). Using traditional manual staging, only PSP patients in stage 6, not earlier stages, had significantly higher clinical severity than stage 2. Cortical tau density and neurofibrillary tangle density in subcortical regions correlated with clinical severity. Overall, our data indicate the potential for highly accurate digital tau aggregate type-specific quantification for neurodegenerative tauopathies; and the importance of studying tau aggregate type-specific burden in different brain regions as opposed to overall tau, to gain insights into the pathogenesis and progression of tauopathies.
Identifiants
pubmed: 37946288
doi: 10.1186/s40478-023-01674-y
pii: 10.1186/s40478-023-01674-y
pmc: PMC10634011
doi:
Substances chimiques
tau Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
178Subventions
Organisme : Medical Research Council
ID : MR/T033371/1
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 103838
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 220258
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00030/14
Pays : United Kingdom
Informations de copyright
© 2023. The Author(s).
Références
Neurology. 2003 May 13;60(9):1495-500
pubmed: 12743238
Mov Disord. 2020 Jun;35(6):984-993
pubmed: 32125724
J Neuropathol Exp Neurol. 2002 Jun;61(6):547-56
pubmed: 12071638
Brain. 2017 Dec 1;140(12):3286-3300
pubmed: 29053874
Acta Neuropathol. 2021 May;141(5):787-789
pubmed: 33778920
J Neuropathol Exp Neurol. 2021 Mar 22;80(4):306-312
pubmed: 33570124
Acta Neuropathol. 2020 Jan;139(1):63-77
pubmed: 31616982
Insights Imaging. 2018 Oct;9(5):745-753
pubmed: 30112675
Perspect Psychol Sci. 2011 May;6(3):299-312
pubmed: 26168520
Neuropathol Appl Neurobiol. 2022 Feb;48(1):e12759
pubmed: 34402107
Cereb Cortex. 2017 Jan 1;27(1):400-410
pubmed: 26464477
J Comp Neurol. 2016 Dec 15;524(18):3865-3895
pubmed: 27187682
Brain. 2007 Jun;130(Pt 6):1566-76
pubmed: 17525140
J Neuropathol Exp Neurol. 1997 Feb;56(2):157-64
pubmed: 9034369
BMC Med Inform Decis Mak. 2011 Jul 29;11:51
pubmed: 21801360
Ann Neurol. 2016 Aug;80(2):247-58
pubmed: 27323247
Mov Disord. 2017 Jun;32(6):853-864
pubmed: 28467028
J Neuropathol Exp Neurol. 2022 Nov 16;81(12):953-964
pubmed: 36269086
Methods. 2014 Nov;70(1):59-73
pubmed: 25034370
Alzheimers Dement. 2011 Jul;7(4):486-9
pubmed: 21784357
Lab Invest. 2019 Jul;99(7):1019-1029
pubmed: 30770886
Neurology. 2008 Sep 2;71(10):743-9
pubmed: 18765650
Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S29-33
pubmed: 26382841
Sci Rep. 2017 Dec 4;7(1):16878
pubmed: 29203879
Psychon Bull Rev. 2018 Feb;25(1):178-206
pubmed: 28176294
Nat Rev Clin Oncol. 2019 Nov;16(11):703-715
pubmed: 31399699
Proc Natl Acad Sci U S A. 2006 Sep 12;103(37):13606-11
pubmed: 16938869
Front Neuroanat. 2013 Sep 02;7:28
pubmed: 24032005
Mach Learn Knowl Discov Databases. 2014;8725:225-239
pubmed: 26023687
Acta Neuropathol. 2020 Aug;140(2):99-119
pubmed: 32383020